Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
A phase 3 clinical trial of solanezumab, an antibody that targets monomeric amyloid, showed no significant slowing of cognitive decline in patients with preclinical Alzheimer’s disease over 240 weeks, despite decreased brain amyloid levels.
Neurology July 26th 2023
Explore this comprehensive study examining the cognitive effects of the MIND diet in older adults with a predisposition to dementia, highlighting the need for more targeted interventions in dietary habits and cognitive health.
Geriatrics July 26th 2023
ReachMD
Discover how prucalopride, typically used as a laxative, is showing promise as a cognitive enhancer in recent neurological research. Learn more about its potential implications for treating cognitive deficits in mood disorders.
Neurology July 5th 2023
MDLinx
New research unveils the distinctive brain connectivity effects of coffee beyond caffeine, suggesting the sensory and psychological aspects of coffee drinking might be as important as the caffeine in enhancing our cognitive readiness.
Unveiling the Cognitive Potential of Multivitamin Supplementation in Older Adults A recent study has unearthed new insights into the effects of multivitamin supplementation on memory performance in older adults, bringing implications for medical professionals and their approach towards cognitive health in their aging patients. Key Points: Additional Points: “We can only speculate at this time. Older adults with cardiovascular risk factors tend to have lower vitamin and mineral circulating levels. Supplementation with multivitamins may help restore these deficiencies, providing [a] secondary benefit to cognitive health.” Adam M. Brickman, PhD, Professor of Neuropsychology at Columbia University Vagelos College of Physicians and Surgeons.
Geriatrics June 13th 2023
Neurology Advisor
Age, a Critical Moderator in Anxiety/Depression and Cognitive Outcomes in MS In recent findings from the ACTRIMS Forum 2023, researchers underscored the crucial role of age in the relationship between mental health and cognitive outcomes in patients with multiple sclerosis (MS). Key Points: “Considering age is necessary when exploring the links between depression or anxiety and cognition in people with MS.” Researchers from the University of Toronto